Prices for new US drugs rose 35% in 2023, more than the previous year

>A high price is justified for a drug with a lot of value to patients, but "prices are just going up and up without any clear rationale as to why," said Dan Ollendorf, chief scientific officer at the Institute for Clinical and Economic Review (ICER), an influential group that evaluates the value and prices of medicines.

Oh that's good.

>He said many rare disease and cancer drugs are not being priced relative to their benefit, but the lack of alternatives gives manufacturers negotiating leverage.

Does this make anyone else a little homicidal or is it just me.

>The U.S. gives drug manufacturers market exclusivity, fee waivers, direct funding for research and development, and tax credits for such orphan treatments.

>"We created a lot of incentives for innovation for rare diseases and the market responded," said Dana Goldman, director of the USC Schaeffer Center for Health Policy & Economics. "The hope is that eventually we will see some therapeutic competition in this space and bring prices down."

It's cool that drugs are being made to treat rare diseases but it kinda sucks that taxpayer money is given to pharmaceutical companies to research and manufacturer this shit just to have them gouge the price because they have all the supply and the people who need it have no other options.